KCT0002380尚未招募未知
Evaluation of the efficacy of Socheongryong-tang for improving nasal symptoms in persistent allergic rhinitis patient : a randomized, cetirizine compared, open-label, pilot study
Woosuk University Korean Medicine Medical Center0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 65(Year)（—）
- 性别
- All
入选标准
- •1) Both male and female patients, 19 to 65 years of age
- •2) Persistent allergic rhinitis patient
- •: Presence of two or more symptoms of allergic rhinitis (rhinorrhea, nasal congestion, nasal itching and sneezing)
- •: Symptoms existing 4 days a week for at least 4 weeks
- •: Persistent allergic rhinitis with a history of at least 2 years, but the symptoms are not controlled by antihistamine treatment
- •: Positive reaction to an allergen in multiple allergen simultaneous test
- •3) After clearly explaining the purpose and characteristics of this clinical study, participants who voluntarily participated in this clinical study and signed the patient consent form
排除标准
- •1) Those with previous history of nose-related or allergy-related diseases and treatment
- •: Those who have congenital deviated nasal septum, nasal polyps, acute chronic sinusitis, asthma symptoms
- •: Those who have used decongestants, cromolyns within the last 3 days
- •: Those who have taken antihistamines and anticholinergics within the last week.
- •: Those with experience using nasal or oral steroids within 2 weeks
- •: Those who have used leukotriene receptor antagonists in the last 4 weeks
- •: Those who have undergone Korean Medicine (acupucture, moxibustion, herbal medicine, cupping, etc) treatment to treat allergic rhinitis within the past month
- •: Those who have received immunotherapy within the last 5 years
- •2) Those who are in a serious medical condition to participate in clinical study
- •: Hypertension (systolic blood pressure greater than 160 mmHg or diastolic blood pressure greater than 100 mmHg)
- •: Diabetes (fasting blood glucose> 126 mg / dL)
- •: Renal dysfunction (serum creatinine level is more than twice the normal range)
- •: Liver function abnormality (AST, ALT value is more than twice the normal range)
- •: Severe condition of hyperlipidemia, anemia, active pulmonary tuberculosis, thyroid disease, other infectious, systematic disease
- •: Those with past or present malignant tumors
- •3) Pregnancy or breast-feeding
- •4) Other, If the clinical researcher judges that it is inappropriate
- •: Those who can not use mobile applications to observe symptoms of allergic rhinitis
研究者
相似试验
招募中
不适用
The efficacy and safety of So-Cheong-Ryong-Tang for perennial allergic rhinitisKCT0002225Kyung Hee University154
已完成
Unknown
Efficacy and safety evaluation study of Oryeongsan for stage I primary hypertensioDiseases of the circulatory systemKCT0009705Wonkwang University, Gwangju Medical Center24
尚未招募
4 期
Observation plan on the effect of Shouhui Tongbian Capsule on constipation of knee joint surgery patients during perioperative periodITMCTR2100004873Hunan Provincial People's Hospital
招募中
不适用
The Efficacy and safety of Hwangryunhaedok-tang on Hangover and study of changes in gut microbiota compositioKCT0003683Pusan National University Korean Medicine Hospital40
已完成
2 期
The study evaluating the efficacy and safety of sorafenib in patients with differentiated thyroid cancer not amendable to radioactive iodine therapy and other alternative treatment.Thyroid cancerJPRN-UMIN000017777niversity of Tsukuba47